The global hyperpigmentation disorder treatment market is expected to reach US$ 6.67 billion in 2022 to US$ 11.78 billion by 2030; it is estimated to register a CAGR of 7.4% from 2022 to 2030.

Key factor driving the market growth is the growing prevalence of skin discoloration disorders. However, the high cost of new hyperpigmentation disorder treatment procedures and a lack of reimbursement privileges for skin rejuvenation treatment methods hamper the market growth.

Market Drivers of the Hyperpigmentation Disorder Treatment Market

Increasing incidences of skin discoloration disorders propel the hyperpigmentation disorder treatment market size. Hyperpigmentation disorders such as melasma, post-inflammatory hyperpigmentation (PIH), and solar lentigines (age spots) are common dermatological conditions caused in individuals with pigmented skin (Blacks, mixed ancestry, Indians, Hispanics, and African Americans). According to an article published by the Royal Australian College of General Practitioners in December 2021, melasma affects ~1% of the global population. However, people with darker skin types (III-V) are more likely to develop it. The prevalence rate in people of Latin American, Southeast Asian, and South Asian ethnicity can be as high as 40%. Hyperpigmentation disorders have a significant impact on the mental and social well-being of patients, thereby driving consumer demand for skin-bleaching cosmetic products. Therefore, as the prevalence of hyperpigmentation disorders continues to rise globally, the demand for skin-lightening agents as a widely accessible treatment option contributes significantly to boosting hyperpigmentation disorder treatment market growth.

Trends in the Hyperpigmentation Disorder Treatment Market

The rising prevalence of hyperpigmentation disorders has led to a surge in the clinical research and development of new innovative products that are safe and efficient for long-term use. With the growing importance of maintaining a healthy lifestyle, cosmeceuticals and cosmetics have become essential to people's daily routines. These new advancements include laser therapies and the utilization of nanotechnology for the formulation of topical treatments. For instance, a study "A Multi-Center, Randomized, Blinded Clinical Study Evaluating the Efficacy and Safety of a Novel Topical Product for Facial Dyschromia," published in the Journal of Drugs in Dermatology (JDD) in May 2023, 43 subjects with mild to severe facial dyschromia were enrolled and randomized to receive either a novel topical product with PATH-3 Technology from Alastin Skincare in Carlsbad, CA, or topical hydroquinone 4% was prescribed to apply twice daily. The study concluded that the hydroquinone 4% group experienced five adverse effects, while no adverse events were reported in the group that used the new topical product with PATH-3 Technology.

Therefore, emerging technologies are expected to be the hyperpigmentation disorder treatment market trends in the near future.

Hyperpigmentation Disorder Treatment Market: Segmental Overview

Based on treatment type, the hyperpigmentation disorder treatment market is segmented into cosmeceutical, chemical peel, cryotherapy, light or laser therapy, microdermabrasion, and others. The cosmeceutical segment held the largest market share in 2022. The microdermabrasion segment is anticipated to register the highest CAGR during 2022-2030.

The market, by disease type, is segmented into age spots, melasma, post-inflammatory, and others. The melasma segment held the largest hyperpigmentation disorder treatment market share in 2022. The post-inflammatory segment is anticipated to grow at the fastest CAGR from 2022 to 2030.

The hyperpigmentation disorder treatment market is segmented based on end users into hospitals, dermatology centers, and others. The hospitals segment held the largest market share in 2022. This can be attributed to the availability of better facilities and skilled physicians in hospitals over other surgical centers to perform minimally invasive procedures. Further, the dermatology centers segment is anticipated to register the highest CAGR during the forecast period.

Hyperpigmentation Disorder Treatment Market: Geographical Overview

Based on geography, the market is segmented into North America, Asia Pacific, Europe, the Middle East & Africa, and South & Central America. In terms of revenue, Asia Pacific dominated the hyperpigmentation disorder treatment market share in 2022. This region's hyperpigmentation disorder treatment market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. India dominated the market in Asia Pacific. This can be attributed to various factors, including the increasing number of patients experiencing hyperpigmentation disorders such as melasma, age spots, and post inflammatory hyperpigmentation, leading to an increase in the research and development of new treatments and medications.

Additionally, the presence of major companies such as L'Or?al S.A., Galderma S.A., and Bayer AG and the availability of technologically innovative treatment methods, such as laser therapies, contribute to the region's market growth. Furthermore, the increasing government healthcare spending creates opportunities for further market growth.